Table 2.
Baseline variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
Odds ratio | 95%CI | P | Odds ratio | 95%CI | P | |
Age (years) | 0.979 | 0.955–1.005 | 0.11 | |||
Sex | 0.637 | 0.302–1.342 | 0.24 | |||
T1 | 0.999 | 0.994–1.005 | 0.87 | |||
T2 | 1.000 | 0.995–1.006 | 0.91 | |||
ALT | 1.004 | 0.991–1.017 | 0.53 | |||
Glucose | 0.607 | 0.433–0.851 | < 0.01 | 0.631 | 0.456–0.874 | < 0.01 |
Creatinine | 1.006 | 0.987–1.025 | 0.55 | |||
Uric acid | 1.003 | 1.000–1.007 | 0.07 | |||
Lymphocytes | 1.668 | 1.026–2.712 | 0.04 | |||
Platelets | 1.006 | 1.000–1.011 | 0.04 | |||
CD4 + T cells | 1.001 | 1.000–1.002 | < 0.01 | 1.001 | 1.000–1.002 | 0.02 |
CD8 + T cells | 1.001 | 0.999–1.002 | 0.28 | |||
B cells | 1.002 | 1.000–1.004 | 0.11 |
CI, 95% confidence interval; T1, duration from the first infection of vaccine to diagnosis; T2, duration from the second infection of vaccine to diagnosis; ALT, alanine aminotransferase